$ANTX
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Healthcare
Sector
Biotechnology
Industry
Eric E. Easom
CEO
22
Employees
$5.34
Current Price
$29.05M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 1 | 1 | $11,601.94 | 2,098 | 1:27.43 |
| Sells | 2 | 9 | $318,204.51 | 52,901 | ||
| 3 months | Buys | 1 | 1 | $11,601.94 | 2,098 | 1:27.43 |
| Sells | 2 | 9 | $318,204.51 | 52,901 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Readnour Robin Shane Director | Sale | 523 | $6.02 | $3,150.71 | View Details |
| Sep 9, 2026 | Readnour Robin Shane Director | Sale | 585 | $6.02 | $3,524.22 | View Details |
| Sep 3, 2026 | Readnour Robin Shane Director | Sale | 3,223 | $6.07 | $19,562.97 | View Details |
| Sep 3, 2026 | Readnour Robin Shane Director | Sale | 2,877 | $6.07 | $17,462.81 | View Details |
| Sep 8, 2026 | Readnour Robin Shane Director | Sale | 4,725 | $6.02 | $28,436.47 | View Details |
| Sep 8, 2026 | Readnour Robin Shane Director | Sale | 5,294 | $6.02 | $31,860.88 | View Details |
| Sep 1, 2026 | Williams Sarah Joanne Principal Accounting Officer | Sale | 272 | $5.53 | $1,504.16 | View Details |
| Sep 1, 2026 | FitzPatrick Margaret M Director | Purchase | 2,098 | $5.53 | $11,601.94 | View Details |
| Aug 17, 2026 | Readnour Robin Shane Director | Sale | 18,706 | $6.01 | $112,389.39 | View Details |
| Aug 17, 2026 | Readnour Robin Shane Director | Sale | 16,696 | $6.01 | $100,312.91 | View Details |
13 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.20
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.